SI1682184T1 - Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov - Google Patents

Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov

Info

Publication number
SI1682184T1
SI1682184T1 SI200332332T SI200332332T SI1682184T1 SI 1682184 T1 SI1682184 T1 SI 1682184T1 SI 200332332 T SI200332332 T SI 200332332T SI 200332332 T SI200332332 T SI 200332332T SI 1682184 T1 SI1682184 T1 SI 1682184T1
Authority
SI
Slovenia
Prior art keywords
granulocyte
pharmaceutical composition
stimulating factor
colony stimulating
stable pharmaceutical
Prior art date
Application number
SI200332332T
Other languages
English (en)
Inventor
Barbara Podobnik
Porekar Vladka Gaberc
Viktor Menart
Original Assignee
Lek Pharmaceuticals D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals D.D. filed Critical Lek Pharmaceuticals D.D.
Publication of SI1682184T1 publication Critical patent/SI1682184T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SI200332332T 2003-11-04 2003-11-04 Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov SI1682184T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2003/005575 WO2005042024A1 (en) 2003-11-04 2003-11-04 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
EP03775645.9A EP1682184B1 (en) 2003-11-04 2003-11-04 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor

Publications (1)

Publication Number Publication Date
SI1682184T1 true SI1682184T1 (sl) 2014-02-28

Family

ID=34531842

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332332T SI1682184T1 (sl) 2003-11-04 2003-11-04 Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov

Country Status (8)

Country Link
US (2) US7585496B2 (sl)
EP (1) EP1682184B1 (sl)
JP (1) JP5129927B2 (sl)
CN (1) CN1878570B (sl)
AU (1) AU2003283664B2 (sl)
CA (1) CA2544432C (sl)
SI (1) SI1682184T1 (sl)
WO (1) WO2005042024A1 (sl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008545754A (ja) * 2005-06-01 2008-12-18 アルザ・コーポレーシヨン ポリエチレングリコール試薬をアシル化するためのバイオコンジュゲーション反応
DE202006020194U1 (de) 2006-03-01 2007-12-06 Bioceuticals Arzneimittel Ag G-CSF-Flüssigformulierung
CN101657187B (zh) * 2007-04-05 2012-07-18 桑多斯股份公司 稳定的水性g-csf制剂
MX2010002448A (es) 2007-08-27 2010-10-04 Biogenerix Ag Formulacion liquida del g-csf conjugado.
AU2008291309B2 (en) 2007-08-27 2013-10-17 Ratiopharm Gmbh Liquid formulation of G-CSF
DE102007040932A1 (de) 2007-08-27 2009-03-05 Biogenerix Ag Flüssigformulierung von G-CSF
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc ｅＭＩＰを有効成分とする水溶性製剤
WO2011023572A1 (de) 2009-08-25 2011-03-03 Basf Se Verfahren zur herstellung wasserabsorbierender polymerpartikel mit verbesserter blutabsorption durch polymerisation von tropfen einer monomerlösung
EP2399572A1 (en) * 2010-06-22 2011-12-28 Sandoz AG Long-term storage of non-glycosylated recombinant human G-CSF
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252069A (en) * 1979-04-13 1981-02-24 Combustion Engineering, Inc. Low load coal bucket
CA2082951C (en) * 1991-03-15 1999-12-21 Robert M. Platz Pulmonary administration of granulocyte colony stimulating factor
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
JP3895109B2 (ja) * 1998-03-06 2007-03-22 中外製薬株式会社 蛋白非添加製剤
US6432449B1 (en) * 1998-05-18 2002-08-13 Amgen Inc. Biodegradable sustained-release alginate gels
ES2216447T3 (es) 1998-08-17 2004-10-16 Pfizer Products Inc. Composiciones proteicas estabilizadas.
US6245740B1 (en) * 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
DE60103940T2 (de) * 2000-02-29 2005-07-28 Pfizer Products Inc., Groton Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
ES2332402T5 (es) * 2000-10-12 2018-05-14 Genentech, Inc. Formulaciones de proteína concentradas de viscosidad reducida
US6579521B2 (en) * 2000-10-20 2003-06-17 Chiron Corporation Methods of therapy for HIV infection
US6439136B1 (en) * 2001-07-03 2002-08-27 Alstom (Switzerland) Ltd Pulverized solid fuel nozzle tip with ceramic component

Also Published As

Publication number Publication date
US7585496B2 (en) 2009-09-08
CA2544432C (en) 2011-06-28
WO2005042024A1 (en) 2005-05-12
JP5129927B2 (ja) 2013-01-30
AU2003283664B2 (en) 2010-08-19
CN1878570A (zh) 2006-12-13
EP1682184A1 (en) 2006-07-26
US8580246B2 (en) 2013-11-12
US20100021419A1 (en) 2010-01-28
JP2007527357A (ja) 2007-09-27
CA2544432A1 (en) 2005-05-12
US20070081971A1 (en) 2007-04-12
CN1878570B (zh) 2010-10-06
EP1682184B1 (en) 2013-10-16
AU2003283664A1 (en) 2005-05-19

Similar Documents

Publication Publication Date Title
GB0320382D0 (en) Pharmaceutical compositions
GB0327723D0 (en) Pharmaceutical compositions
AU2003291103A8 (en) Pharmaceutical composition
EP1603543A4 (en) THERAPEUTIC COMPOSITIONS
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
ZA200605080B (en) Pharmaceutical compositions
IL172814A0 (en) Novel solid pharmaceutical composition comprising amisulpride
HU0301154D0 (en) Pharmaceutical composition
GB0300427D0 (en) Pharmaceutical composition
AU2003250372A8 (en) Pharmaceutical composition
GB2391809B (en) Pharmaceutical composition comprising honey
GB0300531D0 (en) Pharmaceutical compositions
EP1694278A4 (en) GLP-1 PHARMACEUTICAL COMPOSITIONS
EP1608385A4 (en) THERAPEUTIC COMPOSITIONS
EP1648411A4 (en) PHARMACEUTICAL COMPOSITIONS
GB0307866D0 (en) Pharmaceutical composition
EP1699458A4 (en) PHARMACEUTICAL COMPOSITION
GB0329232D0 (en) Pharmaceutical composition
GB0317663D0 (en) Pharmaceutical composition
HK1093896A1 (en) Medicinal composition
SI1682184T1 (sl) Stabilen farmacevtski sestavek, obsegajoč faktor za stimulacijo kolonije granulocitov
EP1600445A4 (en) CURATIVE PREPARATION
GB0300885D0 (en) Pharmaceutical composition
EP1655029A4 (en) MEDICINAL COMPOSITIONS
HK1095737A1 (en) Medicinal composition in solution form